Rapport Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2026 | $-13.1M | $-13.1M | $86.0K | $7.0M |
| Jun 2026 | $-41.5M | $-41.5M | $78.0K | $7.2M |
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2026 | $-13.1M | $-13.1M | $86.0K | $7.0M |
| Jun 2026 | $-41.5M | $-41.5M | $78.0K | $7.2M |